Error: Could not add to watchlist. X
+ Watchlist

Carnegie Fund II - Biotechnology Sub-Fund

CARBIOA:LX
26.67
EUR
As of 12:00 AM EDT 8/26/2016
Fund Type
SICAV
52Wk Range
21.28 - 35.34
1 Yr Return
-24.45%
YTD Return
-19.72%
52Wk Range
21.28 - 35.34
1 Yr Return
-19.33%
YTD Return
-19.72%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 08/26/2016)
26.67
Total Assets (m EUR) (on 07/29/2016)
26.486
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%

Top Fund Holdings

Name Position Value % of Fund
24.40 k 2.43 m 9.16
8.36 k 2.15 m 8.13
25.80 k 1.86 m 7.01
19.30 k 1.66 m 6.28
27.50 k 1.56 m 5.88
14.39 k 1.25 m 4.71
43.00 k 1.23 m 4.65
2.93 k 1.09 m 4.11
5.89 k 1.02 m 3.84
8.40 k 964.54 k 3.64
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
Address
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
Phone
352-40-40-30-1